Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Rubius Therapeutics Inc.

    NASDAQ: RUBY · Real-Time Price · USD
    0.06
    0.00 (8.11%)
    At close: Dec 29, 2023, 9:49 PM

    Rubius Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2022 FY 2021
    Period Ending Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a
    Cost of Revenue
    		 n/a n/a
    Gross Profit
    		 n/a n/a
    Operating Income
    		 -178.45M -194.62M
    Interest Income
    		 819K 91K
    Pretax Income
    		 -179.67M -196.55M
    Net Income
    		 -230.86M -188.82M
    Selling & General & Admin
    		 30.84M 53.03M
    Research & Development
    		 96.41M 141.59M
    Other Expenses
    		 1.82M -1.93M
    Operating Expenses
    		 127.25M 194.62M
    Interest Expense
    		 3.86M 6.43M
    Selling & Marketing Expenses
    		 n/a n/a
    Cost & Expenses
    		 127.25M 194.62M
    Income Tax Expense
    		 51.2M -7.72M
    Shares Outstanding (Basic)
    		 90.31M 87.95M
    Shares Outstanding (Diluted)
    		 90.31M 87.95M
    EPS (Basic)
    		 -2.56 -2.15
    EPS (Diluted)
    		 -2.56 -2.15
    EBITDA
    		 -118.35M -194.62M
    EBIT
    		 -175.8M -190.11M
    Depreciation & Amortization
    		 6.25M 7.72M

    Add to Watchlist